Success Stories: A Research Fellow in Biomedical Science from India Obtains NIW Approval, Retains Service for EB1-A, and Gets Another Approval, Thanks to Our Team at NAILG
Client’s Testimonial:
“Thank you very much! I truly appreciate your help at every step of my application!”
On April 11th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Research Fellow
Country of Origin: India
State of Residence at the Time of Filing: Maryland
Approval Notice Date: April 11th, 2022
Processing Time: 3 months, 5 days
Case Summary:
An expert in the field of biomedical science from India came to NAILG seeking help with his NIW (National Interest Waiver) petition. As is our custom with new clients, we first ensured that he knew the task ahead and then signed the attorney-client forms with him. Soon our team started exploring his work in the area and found the following:
- His proposed endeavor is to continue his research evaluating how changes in RNA impact protein synthesis and influence the offset and progression of various health burdens, including cancer, aging, and infectious diseases using his expertise in RNA folding, RNA-protein interaction, ribosome assembly, and the mechanisms of protein synthesis to identify novel therapeutic targets for the treatment of these disorders.
- Based on his education and research background, he is currently employed as a research fellow at a prestigious institution in the U.S.A.
- His research advancing his proposed endeavor is of great importance because it involves clarifying how changes in RNA influence the offset and progression of various diseases, including cancer.
- This proposed endeavor also has broad implications for the United States, since the impact of RNA biology research on the advancement of cancer diagnostics and treatment is immense. His work thus has numerous positive implications for U.S. public health.
- Due to its clear national importance, his work has been supported with funding from the National Institutes of Health and the Department of Biotechnology of the Government of India’s Ministry of Science & Technology.
- He has also completed at least 12 reviews to date for well-known journals in her field of study.
- His work has resulted in 8 peer-reviewed journal articles (6 of them first-authored).
- These publications have also been cited a total of 205 times. That is, his publications have been cited by researchers in at least 30 countries, according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical science.
- Furthermore, he has pursued research directly related to his proposed endeavor for 12 years.
- And finally, we collected 4 letters of recommendation supporting his work for the country, one of which had the following passage in it:
“Though national awareness of tuberculosis infection in the United States has taken a backseat to the recent COVID-19 pandemic, the domestic impact of this disease is still substantial. The COVID-19 pandemic is suspected to have led to a significant underreporting of tuberculosis incidence, which is estimated to affect thousands of Americans. [The client’s] detailed data related to its cellular functions in mycobacteria continue to support the development of novel treatments for this disease. In conclusion, [client’s] innovative research is an essential asset in the nation’s continued efforts to eradicate tuberculosis infections from the United States.”
We then used these bits of information to build him a customized petition winning him both approvals without any RFE issued. We are glad to have had the opportunity to work with him, and we thank him for his trust in us.